Easterly Investment Partners’s Quest Diagnostics DGX Stock Holding History

Easterly Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.59M	Buy	+35,800	New	+$7.03M	0.39%	53
2025 Q3	–	Sell	-10,379	Closed	-$1.86M	–	205
2025 Q2	$1.86M	Buy	+10,379	New	+$1.8M	0.13%	119
2020 Q4	–	Sell	-118,942	Closed	-$13.6M	–	137
2020 Q3	$13.6M	Sell	118,942 -5,314	-4%	-$628K	0.54%	34
2020 Q2	$14.2M	Sell	124,256 -299,323	-71%	-$31.7M	0.64%	35
2020 Q1	$34M	Buy	423,579 +409,692	+2,950%	+$42.4M	1.51%	30
2019 Q4	$1.48M	Sell	13,887 -195,290	-93%	-$20.4M	0.04%	50
2019 Q3	$22.4M	Sell	209,177 -113,581	-35%	-$11.7M	0.63%	34
2019 Q2	$32.9M	Sell	322,758 -1,084,523	-77%	-$104M	0.82%	35
2019 Q1	$127M	Buy	+1,407,281	New	+$122M	3.05%	13

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Easterly Investment Partners's DGX Position: Q2 2026 in Review

Easterly Investment Partners opened a new position in Quest Diagnostics (DGX) in Q2 2026: 35,800 shares worth $7.59M. The stake represents 0.39% of the portfolio and ranks #53 among its holdings. This is a return to the name: Easterly Investment Partners previously reported a position in DGX as recently as Q2 2025.

Easterly Investment Partners first reported a position in DGX in Q1 2019 and has held it in 9 quarters since. The position peaked at $127M in Q1 2019. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Easterly Investment Partners held 35,800 shares of Quest Diagnostics worth $7.59M as of Q2 2026.
Quest Diagnostics was a new Easterly Investment Partners position in Q2 2026.
Quest Diagnostics made up 0.39% of Easterly Investment Partners's portfolio in Q2 2026, its #53 holding.
Easterly Investment Partners first reported a position in Quest Diagnostics in Q1 2019 and has held it in 9 quarters since.
Easterly Investment Partners's Quest Diagnostics position peaked at $127M in Q1 2019.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Easterly Investment Partners's 13F filing for Q2 2026, filed 23 Jul 2026.